FindTrial
Sign In

Association of HLA class II allele variants in patients with Hepatitis B viral infection.

A cross- sectional study on association of HLA class II allele variants in patients with Hepatitis B viral infection attending tertiary care hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/01/011460
Enrollment
140
Registered
2018-01-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D899- Disorder involving the immune mechanism, unspecified Health Condition 2: null- Hepatitis B Virus(HBV) infected patients.

Interventions

None listed

Sponsors

Chettinad Acadey of Research and Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with seropositive for HBV along with control, will be included as a source of samples to carry out this study

Exclusion criteria

Exclusion criteria: Patients with Hepatitis of all other causes, leptospira and HIV infection will be excluded

Design outcomes

Primary

MeasureTime frame
Prevalence rate of HBV infection during 2014 to 2015 at a tertiary care hospital. Timepoint: Total number of sample received for HBV test: 9711 Total number of HBV positive case: 294 Prevalence rate was found to be 3%—

Countries

India

Contacts

Public ContactDr A S Shameem Banu

Chettinad Academy of Research and Education

prabina89@gmail.com9710496169

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026